Principal AI/Deep Learning Engineer at Nautilus Biotechnology

Seattle, Washington, United States

Apply Now

$224,000 – $337,000Compensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, HealthcareIndustries

Requirements

PhD or Master's degree in Data Science, Artificial Intelligence, Computer Science, Statistics, Mathematics, or a related field highly desired
8+ years of experience in designing, developing, and deploying machine learning models and data science solutions
4+ years in hands-on GenAI application development
Experience developing and implementing bespoke deep-learning approaches (biological/proteomics context preferred but not required)
Demonstrated ability to translate research prototypes into robust, scalable production systems
Strong background in data engineering, including data pipelines, ETL processes, and data warehouses supporting traditional and AI-driven applications
Experience with MLOps: model deployment, monitoring, and lifecycle management in cloud or on-prem environments, debugging ML models
Experience with explainable AI and inferential machine learning models preferred
Familiarity with best practices in software engineering including code quality, testing, version control, and maintainability
Experience leading cross-functional strategy and execution
Strong problem-solver who collaborates well across disciplines
Effective communicator with both technical and non-technical audiences
Passionate about science and advancing human health

Responsibilities

Establish Nautilus Biotechnology as the premier proteomics data source for AI applications
Lead organization-wide AI strategy, identifying high-impact use cases and driving adoption across teams
Collaborate with data engineers to build robust infrastructure supporting AI/ML model training, deployment, and monitoring
Establish best-practices in AI-enhanced software engineering
Integrate AI/ML solutions into production environments, ensuring reliability, scalability, and maintainability
Work with product, bioinformatics, and software teams to add AI features to our data analysis portal, helping customers quickly extract biological insights from Nautilus data
Ensure customers can readily interface their Nautilus data with popular AI tooling
Marry cutting edge AI/ML approaches with our unique single-molecule, intact protein data to reveal previously inaccessible biological information

Skills

Deep Learning

Machine Learning

Data Engineering

Model Training

Model Deployment

MLOps

Software Engineering

Proteomics

Bioinformatics

Nautilus Biotechnology

Proteomics platform for drug development insights

About Nautilus Biotechnology

Nautilus Biotechnology focuses on the study of proteins, known as proteomics, to enhance drug development. The company has created a platform that helps researchers gain detailed insights into how drug targets function in relation to health and disease. This platform allows users to identify and prioritize drug targets that are more likely to succeed in clinical trials, which helps to streamline the drug discovery process and lower costs compared to traditional methods. Nautilus Biotechnology primarily serves pharmaceutical companies, research institutions, and biotech firms, providing them with tools to improve their research and clinical outcomes. The company's goal is to unlock the potential of the proteome to drive advancements in biology and medicine, ultimately benefiting global health.

San Carlos, CaliforniaHeadquarters

2016Year Founded

$294.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Risks

Potential delays in platform launch could impact revenue and investor confidence.

Reliance on SkyWater for bio chip production introduces supply chain dependencies.

Economic downturn affecting SPAC companies may lead to stock price volatility.

Differentiation

Nautilus Biotechnology integrates diverse expertise to revolutionize proteomics and drug development.

Their platform offers deep insights into drug targets, enhancing clinical success rates.

Nautilus collaborates with semiconductor firms to advance precision medicine through enhanced protein analysis.

Upsides

The trend of personalized medicine boosts demand for Nautilus' advanced proteomics platform.

Recent mass spectrometry advancements improve Nautilus' proteomic analysis sensitivity and accuracy.

AI integration in proteomics enhances Nautilus' data analysis and interpretation capabilities.

Land your dream remote job 3x faster with AI

Try Jobo Free